Pnc Financial Services Group, Inc. Idera Pharmaceuticals, Inc. Transaction History

Pnc Financial Services Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.23 - $0.43 $46 - $86	200 Added 6.15%	3,450 $1,000
Q1 2021 May 07, 2021	SELL	$1.23 - $5.98 $3,690 - $17,940	-3,000 Reduced 48.0%	3,250 $4,000
Q4 2020 Feb 12, 2021	BUY	$2.09 - $5.18 $6,270 - $15,540	3,000 Added 92.31%	6,250 $22,000
Q3 2020 Nov 06, 2020	BUY	$1.71 - $2.68 $3,420 - $5,360	2,000 Added 160.0%	3,250 $6,000
Q3 2018 Nov 09, 2018	BUY	$5.53 - $11.36 $6,912 - $14,200	1,250 New	1,250 $0

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.